These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32719075)

  • 21. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
    Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
    Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Fournier S; Muller O; Benedetto U; Roffi M; Pilgrim T; Eberli FR; Rickli H; Radovanovic D; Erne P; Cook S; Noble S; Fesselet R; Zuffi A; Degrauwe S; Masci P; Windecker S; Eeckhout E; Iglesias JF;
    Clin Res Cardiol; 2018 Apr; 107(4):338-346. PubMed ID: 29222592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LidocAine Versus Opioids In MyocarDial infarction: the AVOID-2 randomized controlled trial.
    Fernando H; Nehme Z; Milne C; O'Brien J; Bernard S; Stephenson M; Myles PS; Lefkovits J; Peter K; Brennan A; Dinh D; Andrew E; Taylor AJ; Smith K; Stub D
    Eur Heart J Acute Cardiovasc Care; 2023 Jan; 12(1):2-11. PubMed ID: 36494194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different strategies on high thrombus burden in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary catheterization.
    Xiao Y; Fu X; Wang Y; Fan Y; Wu Y; Wang W; Zhang Q
    Coron Artery Dis; 2019 Dec; 30(8):555-563. PubMed ID: 30998610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ischemic Postconditioning After Routine Thrombus Aspiration During Primary Percutaneous Coronary Intervention: Rationale and Design of the POstconditioning Rotterdam Trial.
    Yetgin T; van Kranenburg M; Ten Cate T; Duncker DJ; de Boer MJ; Diletti R; van Geuns RM; Zijlstra F; Manintveld OC
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):508-514. PubMed ID: 27022882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction: The ATLANTIC-H²⁴ Analysis.
    Montalescot G; van 't Hof AW; Bolognese L; Cantor WJ; Cequier A; Chettibi M; Collet JP; Goodman SG; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Licour M; Merkely B; Salhi N; Silvain J; Storey RF; Ten Berg JM; Tsatsaris A; Zeymer U; Vicaut E; Hamm CW;
    JACC Cardiovasc Interv; 2016 Apr; 9(7):646-56. PubMed ID: 26952907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of preprocedural TIMI flow on clinical outcome in low-risk patients with ST-elevation myocardial infarction: Results from the ATLANTIC study.
    Bauer T; Zeymer U; Diallo A; Vicaut E; Bolognese L; Cequier A; Huber K; Montalescot G; Hamm CW; Van't Hof AW;
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):494-500. PubMed ID: 31067010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
    Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
    Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of periprocedural intravenous morphine use on clinical outcomes in ST-elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention: Systematic review and meta-analysis.
    Batchelor R; Liu DH; Bloom J; Noaman S; Chan W
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):76-88. PubMed ID: 31654491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
    BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-Derived Thrombogenicity Measured by Total Thrombus-Formation Analysis System in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Kikuchi S; Tsukahara K; Ichikawa S; Abe T; Minamimoto Y; Kimura Y; Akiyama E; Nakayama N; Okada K; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; Tamura K; Kimura K
    Circ J; 2020 May; 84(6):975-984. PubMed ID: 32188836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
    Danchin N; Puymirat E; Cayla G; Cottin Y; Coste P; Gilard M; Goldstein P; Braun F; Belle L; Montalescot G; Ferrières J; Schiele F; Simon T;
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007241. PubMed ID: 30354592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.
    Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of thrombus aspiration during ST-Elevation Myocardial Infarction: a six month composite endpoint and risk of stroke analyses of the TASTE trial.
    Olivecrona GK; Lagerqvist B; Fröbert O; Gudnason T; Maeng M; Råmunddal T; Haupt J; Kellerth T; Stewart J; Sarno G; Jensen J; Östlund O; James SK
    BMC Cardiovasc Disord; 2016 Apr; 16():62. PubMed ID: 27036735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of undersized- versus oversized-stenting approaches in ST-elevation myocardial infarction.
    Nagumo S; Wakabayashi K; Tsujiuchi M; Sato C; Yamauchi T; Nakadate T; Suzuki H
    Cardiovasc Revasc Med; 2016 Sep; 17(6):362-8. PubMed ID: 27161859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0-1 coronary flow: Insights from an all comers registry.
    Luz A; Silveira I; Brochado B; Rodrigues P; João Sousa M; Santos R; Trêpa M; Santos M; Silveira J; Torres S; Leite-Moreira AF; Carvalho H
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):531-539. PubMed ID: 28191743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
    Butt N; Bache-Mathiesen LK; Ushakova A; Nordrehaug JE; Jensen SE; Munk PS; Danchin N; Dubois-Rande JL; Hansen HS; Paganelli F; Corvoisier PL; Firat H; Erlinge D; Atar D; Larsen AI
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):302-312. PubMed ID: 32403934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Capranzano P; Capodanno D; Bucciarelli-Ducci C; Gargiulo G; Tamburino C; Francaviglia B; Ohno Y; La Manna A; Antonella S; Attizzani GF; Angiolillo DJ; Tamburino C
    Eur Heart J Acute Cardiovasc Care; 2016 Sep; 5(5):475-86. PubMed ID: 26758542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.